Roderick van den Bergh

Targeted prostate biopsy may overestimate ISUP GG when compared to systematic biopsy, but this mainly occurs in smaller lesions. sciencedirect.com/science/articl… @EAU_YAUProstate @Uroweb

@declangmurphy Target Bx ISUP GG 2 ≈ Systematic Bx ISUP 1

53yo PSA 5.2. PIRADS 3. TP Bx reveals a single core 1.7mm grade group 2. Pattern 4 “too small to quantify”. PSMA minimal avidity (PRIMARY score 1). Original Urologist said he “would be dead within 5 years if he did not have a radical prostatectomy”. Mmmm. Am I missing something?

@gu_onc @Uroweb @declangmurphy @RenuEapen Please check out the latest @gu_onc podcast covering #EAU25, including discussion on the pros and cons of the @neurosafeproof trial. Thanks for having me @declangmurphy! @EAU_YAUProstate @Uroweb @CanUrolAssoc @UrologieNL

Part 1 of our #EAU25 GU Cast conference Highlights has dropped! Fantastic chats with some great friends of the pod please check it out! @Uroweb @declangmurphy @RenuEapen youtu.be/IQlbX0PqWnk?si…

@veerukasi @TheLancetOncol 👍 Congrats! Great study providing insight in a field with low level of evidence! @Uroweb @gu_onc @EAU_YAUProstate

🚨Neurosafe RCT(n=407) at gamechanger sess by Greg Shaw #EAU25. In men with good baseline erections having RALP, 12 mth erectile function better with neurosafe technique vs SOC (IIEF 12.7vs9.7, p<0.001) & early continence better. Published @TheLancetOncol thelancet.com/journals/lanon…

@JGomezRivas @UrologiaClinico @IIS_IdISSC @anestesiaHCSC @iClinicoMadrid @JesusMorenosier @juliomayol @ortegapolledo @InfoAeu So that’s where you were!

Behind every successful live surgery session at #EAU25 is an incredible team working behind the scenes, from the operating room 🏥 to the tech desk 🎛️, from logistics 📦 to clinical planning Every detail matters 🔍, and every team member played a vital role in ensuring patient safety 🛡️, surgical excellence, and educational value 🎓 for all attendees Thanks 🎉 to the surgeons 🧑🏻‍⚕️👩🏻‍⚕️👨🏻‍⚕️, nurses 💉, anesthesiologists, coordinators 📋, audiovisual experts 🎥, and @Uroweb staff 🙌 who made it all possible. #Teamwork #EAU25 #SurgicalEducation #Urology #BehindTheScenes #somosclinico

@veerukasi @TheLancetOncol 🛎️ Beware of bias! Men were NOT blinded to nerve-sparing status! @gu_onc @Uroweb @EAU_YAUProstate @urotoday

@deberli Looking forward!

Uro-Onkologisches #Symposium "Hot Topics in Uro-Oncology" am Freitag, den 24. Januar 2025 in Zürich, Careum Auditorium. Spannende und kontroverse Themen mit erstklassigen Redner:innen. Melden Sie sich jetzt an: usz.ch/veranstaltung/…

Thanks for inviting me to the outstanding #apcc24 in my old fellowship city #Melbourne! @phildundee @MarcDiocera @DrBenTran @DrDanielMoon @uroweb @EAU_YAUProstate @IMRASurgical

@DrMarniqueB 👋

Where’s all the urology content? 90% of my home feed is American politics and the founder of X. Has anyone else’s Urology feed been taken over? Or is no one tweeting anymore? Team urology…have we moved on to another platform? #urosome

@JGomezRivas @Uroweb @EAUYAUrology @JLVasquez82 @eau_yuo @veerukasi @NDowJames @ameliapietr1 @AngeloTerrito @dr_rajwa @PheVeronique @Cacciamani_MD @Ric_Campi Forever young

As I prepare to embark on the next chapter of my @Uroweb journey, I want to take a moment to express my gratitude to @EAUYAUrology I have been filled with remarkable experiences, and I am immensely grateful for the support, collaboration, and friendship collected through the years. Working alongside such talented and dedicated people has been a true privilege and together, we have achieved great things Continue to pursue your passions, believe in your potential, and strive for excellence in all that you do. I wish you all the very best for the future under @GiorgioI_Russo leadership All the best!

@AustProstate Looking very much forward to join #apcc24 in Melbourne! @uroweb @EAU_YAUProstate

Did you know A/Prof @roodvdb will be joining us for #apcc24, his presentations include Clinical and Molecular Stratification of Men with Biochemical Recurrence After Radical Prostatectomy. View the full program at prostatecancerconference.org.au #prostatecancer #urology

@bavilima @JGomezRivas The advantage of upfront combination therapy may be questioned in some subgroups, especially at lower risk spectrum.

Cardiovascular events & ARPIs🚨 ➡️24 RCTs ➡️22166 patients (63-77 years) ➡️addition of ARPI to ADT increased risk of: *all grade CV event (RR, 1.75) ‼️ *grade 3 or higher CV events (RR, 2.10)‼️ *cerebrovascular events (RR, 1.86)‼️ *CV-related death (RR, 2.02)‼️ jamanetwork.com/journals/jamao… @OncoAlert @OncoReporte @gilmorgan @nataliagandur @FernandoOnco @realbowtiedoc @DenizCanGuven1 @BiagioRicciutMD @ElisaAgostinett @dr_yakupergun @lungoncdoc @ElisaAgostinett @to_be_elizabeth @ADesaiMD @anacardosomd @drdanielvargas @FabioSchutz @sandrocavallero @davidmuniz @fsabino_onco @jardim_denis @Martin_AngelMD @fedelosco @karima_oualla @LHAurologia @GGandaglia @LoebStacy @F_Sanguedolce @ClaytonLauMD @JoshMeeks @JGomezRivas @WbusatoJr @clovis_fraga @psalustiano @DrMourato

@TheGiesen @joniau @EAU_YAUProstate @Uroweb @ESRUrology @EAUYAUrology @eau_yuo @GGandaglia @dr_rajwa Congrats!

🤩Thrilled to announce I've been accepted to the YAU PCa Working Group of the EAU! 🌟 Excited for these collaborative opportunities 💪 🔬 Looking forward to advancing PCa research together with like-minded and world-reknowned colleagues! #PCa #EAU @joniau @EAU_YAUProstate

@PheVeronique @EurUrolOpen @sproietti81 @Walzjc @EUplatinum @JimCatto @UrowebESU @eau_yuo @EAUYAUrology @MarkusGraefen @RassweilerJens @AStenzl @u_capitanio @evanliats @LoebStacy @PorpigliaF @qdtrinh @heinvanpoppel @declangmurphy Great team 💫

📢Breaking news 🔝The 2023 @EurUrolOpen Impact factor has reached 3.2 ‼️ 👏Excellent editorial team @sproietti81 @roodvdb carmenmir cathypierce biancaneal 🥇Under the leadership of @Walzjc 🙏Reviewers, authors & readers @EUplatinum @JimCatto @UrowebESU @eau_yuo @EAUYAUrology

@joniau @JGomezRivas @Ecastromarcos @declangmurphy @ZilliThomas #uroonco24 @uroweb

To consider when applying one-size-fits-all upfront combination therapy in M+HSPC: - Undertreated trial control arms - Mismatch age in real-life and trials - Increase CV toxicity Postpone intensification of therapy until CRPC? @AlexSherryMD @LauraBukavinaMD @UroTaji

🚧 Adding ARSI to ADT for M+ PCa gives additional risk CV-events. For which patients does the benefit of upfront combination Tx tip over to a risk and sequenced initiation at CRPC may be preferable? @BertrandTOMBAL @Silke_Gillessen @NivenMehra @dr_rajwa @DrBenTran @Ecastromarcos

@KariTikkinen @cgratzke @EurUrolFocus @declangmurphy @EUplatinum @Uroweb @helsinkiuni @HelsinkiUniMed @HUS_fi @Uniklinik_Fr @GuyattGH @Prof_Nick_James @veerukasi @EBMUrology Great summer reads ☀️

🔥Prof @cgratzke, the Editor-In-Chief interviewed on our two #EBM series published in @EurUrolFocus (>20 articles) Interview available at youtu.be/qk-7cPPoVes?si… More on 1st series: x.com/karitikkinen/s… More on 2nd series: x.com/karitikkinen/s… 📸 @declangmurphy

@DrShakuriRad Get some more info on the case?

@roodvdb Same as your would be

Can we just stop this nonsense? #UroSoMe